HM Payson & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.82M | Sell |
5,821
-914
| -14% | -$443K | 0.05% | 135 |
|
|
2024
Q4 | $2.71M | Sell |
6,735
-340
| -5% | -$137K | 0.05% | 134 |
|
|
2024
Q3 | $3.29M | Sell |
7,075
-12,330
| -64% | -$5.73M | 0.06% | 131 |
|
|
2024
Q2 | $9.1M | Buy |
19,405
+17,389
| +863% | +$8.15M | 0.17% | 79 |
|
|
2024
Q1 | $843K | Sell |
2,016
-6
| -0.3% | -$2.51K | 0.02% | 224 |
|
|
2023
Q4 | $823K | Buy |
2,022
+1,975
| +4,202% | +$804K | 0.02% | 224 |
|
|
2023
Q3 | $16.3K | Buy |
47
+25
| +114% | +$8.69K | ﹤0.01% | 763 |
|
|
2023
Q2 | $7.74K | Hold |
22
| – | – | ﹤0.01% | 822 |
|
|
2023
Q1 | $6.93K | Buy |
+22
| New | +$6.93K | ﹤0.01% | 832 |
|
|
2022
Q4 | – | Sell |
-12
| Closed | -$3K | – | 1005 |
|
|
2022
Q3 | $3K | Sell |
12
-3
| -20% | -$750 | ﹤0.01% | 894 |
|
|
2022
Q2 | $4K | Buy |
15
+3
| +25% | +$800 | ﹤0.01% | 918 |
|
|
2022
Q1 | $3K | Buy |
+12
| New | +$3K | ﹤0.01% | 955 |
|
|
2021
Q4 | – | Sell |
-35
| Closed | -$6K | – | 1173 |
|
|
2021
Q3 | $6K | Buy |
+35
| New | +$6K | ﹤0.01% | 892 |
|
|
2021
Q2 | – | Sell |
-107
| Closed | -$23K | – | 1184 |
|
|
2021
Q1 | $23K | Sell |
107
-37
| -26% | -$7.95K | ﹤0.01% | 728 |
|
|
2020
Q4 | $34K | Hold |
144
| – | – | ﹤0.01% | 687 |
|
|
2020
Q3 | $39K | Hold |
144
| – | – | ﹤0.01% | 603 |
|
|
2020
Q2 | $42K | Hold |
144
| – | – | ﹤0.01% | 552 |
|
|
2020
Q1 | $34K | Hold |
144
| – | – | ﹤0.01% | 551 |
|
|
2019
Q4 | $32K | Hold |
144
| – | – | ﹤0.01% | 652 |
|
|
2019
Q3 | $24K | Sell |
144
-47
| -25% | -$7.83K | ﹤0.01% | 701 |
|
|
2019
Q2 | $35K | Buy |
+191
| New | +$35K | ﹤0.01% | 658 |
|